I-Mab

/I-Mab

IPO

I-Mab

Biopharmaceutical

We are a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel or highly differentiated biologics to treat diseases with significant unmet medical needs, particularly cancers and autoimmune disorders.

Symbol

IMAB

Price Range
$12.00 - $15.00

Final Shares
7,400,000

Anticipated Date
January 17, 2020

Underwriters
JEFFERIES LLC

This offering is no longer available

To view the prospectus for I-Mab IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277